{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Rochester&page=64&state=Minnesota", "query": { "state": "Minnesota", "city": "Rochester", "page": 64 }, "page_size": 10 }, "pagination": { "page": 64, "page_size": 10, "total_count": 9154, "total_pages": 916, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Rochester&page=65&state=Minnesota&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Rochester&page=63&state=Minnesota&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-15T11:51:06.566Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00578812", "title": "PCM Cervical Disc System", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Radiculopathy", "Myelopathy" ], "interventions": [ { "name": "Anterior Cervical Discectomy and Fusion (ACDF)", "type": "DEVICE" }, { "name": "PCM Cervical Disc", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "NuVasive", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 494, "start_date": "2005-01", "completion_date": "2014-08", "has_results": true, "last_update_posted_date": "2015-07-07", "last_synced_at": "2026-11-15T11:51:06.566Z", "location_count": 23, "location_summary": "Beverly Hills, California • Greenwood Village, Colorado • Washington D.C., District of Columbia + 18 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Greenwood Village", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00578812" }, { "nct_id": "NCT06671912", "title": "Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam Trial", "overall_status": "SUSPENDED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Anatomic Stage 0 Breast Cancer AJCC v8", "Anatomic Stage 1 Breast Cancer AJCC v8", "Anatomic Stage IIA Breast Cancer AJCC v8", "Estrogen Receptor-Positive Breast Carcinoma", "HER2-Negative Breast Carcinoma", "Breast Ductal Carcinoma In Situ", "Breast Lobular Carcinoma In Situ" ], "interventions": [ { "name": "Anastrozole", "type": "DRUG" }, { "name": "Letrozole", "type": "DRUG" }, { "name": "Exemestane", "type": "DRUG" }, { "name": "Tamoxifen", "type": "DRUG" }, { "name": "Mammogram", "type": "PROCEDURE" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Dual X-ray Absorptiometry", "type": "BIOLOGICAL" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "DRUG", "PROCEDURE", "BIOLOGICAL", "OTHER" ], "sponsor": "Alliance for Clinical Trials in Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1556, "start_date": "2025-02-19", "completion_date": "2031-11-30", "has_results": false, "last_update_posted_date": "2026-09-02", "last_synced_at": "2026-11-15T11:51:06.566Z", "location_count": 728, "location_summary": "Anchorage, Alaska • Gilbert, Arizona • Goodyear, Arizona + 559 more", "locations": [ { "city": "Anchorage", "state": "Alaska" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Goodyear", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT06671912" }, { "nct_id": "NCT05077722", "title": "Monitoring of Sleep and Behavior of Children 3-7 Years Old Receiving Parent-Child Interaction Therapy With the Help of Artificial Intelligence", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Disruptive Behavior", "Attention-deficit Hyperactivity", "Oppositional Defiant Disorder" ], "interventions": [ { "name": "Garmin", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "3 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "3 Years to 99 Years" }, "enrollment_count": 100, "start_date": "2022-03-24", "completion_date": "2023-12-01", "has_results": false, "last_update_posted_date": "2024-03-22", "last_synced_at": "2026-11-15T11:51:06.566Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT05077722" }, { "nct_id": "NCT06195072", "title": "Platform Clinical Study for Conquering Scleroderma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Interstitial Lung Disease Due to Systemic Disease", "Scleroderma" ], "interventions": [ { "name": "Amlitelimab", "type": "DRUG" }, { "name": "BI 1015550 (Nerandomilast)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Scleroderma Research Foundation, Inc.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 400, "start_date": "2024-04-15", "completion_date": "2026-11", "has_results": false, "last_update_posted_date": "2026-08-18", "last_synced_at": "2026-11-15T11:51:06.566Z", "location_count": 34, "location_summary": "Birmingham, Alabama • Los Angeles, California • Palo Alto, California + 23 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06195072" }, { "nct_id": "NCT01353677", "title": "Feasibility of Collecting Quality of Life Data in Collaboration With the Stem Cell Therapeutic Outcomes Database", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Hematopoietic Stem Cell Transplantation" ], "interventions": [], "intervention_types": [], "sponsor": "Center for International Blood and Marrow Transplant Research", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 390, "start_date": "2011-07", "completion_date": "2014-10-30", "has_results": false, "last_update_posted_date": "2017-07-25", "last_synced_at": "2026-11-15T11:51:06.566Z", "location_count": 7, "location_summary": "Gainesville, Florida • Rochester, Minnesota • New York, New York + 3 more", "locations": [ { "city": "Gainesville", "state": "Florida" }, { "city": "Rochester", "state": "Minnesota" }, { "city": "New York", "state": "New York" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01353677" }, { "nct_id": "NCT02091375", "title": "Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Epilepsy", "Dravet Syndrome" ], "interventions": [ { "name": "GWP42003-P 20 mg/kg/day Dose", "type": "DRUG" }, { "name": "Placebo control", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Jazz Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "2 Years to 18 Years" }, "enrollment_count": 120, "start_date": "2015-03-30", "completion_date": "2015-11-26", "has_results": true, "last_update_posted_date": "2022-09-28", "last_synced_at": "2026-11-15T11:51:06.566Z", "location_count": 13, "location_summary": "Miami, Florida • Orlando, Florida • Atlanta, Georgia + 10 more", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT02091375" }, { "nct_id": "NCT02763319", "title": "A Trial to Evaluate the Efficacy and Safety of Tafasitamab With Bendamustine (BEN) Versus Rituximab (RTX) With BEN in Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Diffuse Large B-cell Lymphoma" ], "interventions": [ { "name": "Rituximab (RTX)", "type": "DRUG" }, { "name": "Tafasitamab", "type": "DRUG" }, { "name": "Bendamustine (BEN)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Incyte Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 453, "start_date": "2016-11-28", "completion_date": "2024-06-21", "has_results": true, "last_update_posted_date": "2025-07-17", "last_synced_at": "2026-11-15T11:51:06.566Z", "location_count": 18, "location_summary": "Anaheim, California • Bakersfield, California • Burbank, California + 15 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Bakersfield", "state": "California" }, { "city": "Burbank", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02763319" }, { "nct_id": "NCT00068822", "title": "Vertebroplasty for the Treatment of Fractures Due to Osteoporosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Spinal Fractures", "Osteoporosis" ], "interventions": [ { "name": "Percutaneous vertebroplasty", "type": "DEVICE" }, { "name": "Sham vertebroplasty", "type": "PROCEDURE" } ], "intervention_types": [ "DEVICE", "PROCEDURE" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 131, "start_date": "2003-04", "completion_date": "2009-09", "has_results": true, "last_update_posted_date": "2012-09-27", "last_synced_at": "2026-11-15T11:51:06.566Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00068822" }, { "nct_id": "NCT00319501", "title": "Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Seizures", "Epilepsies, Partial", "Epilepsy, Complex Partial", "Epilepsy, Generalized", "Epilepsy" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Vanquix Auto-Injector (Diazepam Injection)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 234, "start_date": "2006-01", "completion_date": "2014-07", "has_results": true, "last_update_posted_date": "2016-09-23", "last_synced_at": "2026-11-15T11:51:06.566Z", "location_count": 86, "location_summary": "Northport, Alabama • Little Rock, Arkansas • Irvine, California + 44 more", "locations": [ { "city": "Northport", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Irvine", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Newport Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00319501" }, { "nct_id": "NCT01752101", "title": "Identification of a Plasma Proteomic Signature for Lung Cancer", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Precancerous Conditions", "Carcinoma" ], "interventions": [], "intervention_types": [], "sponsor": "Integrated Diagnostics", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 475, "start_date": "2012-10", "completion_date": "2014-12", "has_results": false, "last_update_posted_date": "2015-01-09", "last_synced_at": "2026-11-15T11:51:06.566Z", "location_count": 12, "location_summary": "San Francisco, California • Miami, Florida • Anniston, Georgia + 9 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Anniston", "state": "Georgia" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Burlington", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01752101" } ] }